Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models.

[1]  Jacqueline D. Niles,et al.  Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. , 2007, European urology.

[2]  C. Altenbach,et al.  Sugar binding induces an outward facing conformation of LacY , 2007, Proceedings of the National Academy of Sciences.

[3]  Eva M. Sevick-Muraca,et al.  Dual-Labeled Trastuzumab-Based Imaging Agent for the Detection of Human Epidermal Growth Factor Receptor 2 Overexpression in Breast Cancer , 2007, Journal of Nuclear Medicine.

[4]  J. Kovar,et al.  A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models. , 2007, Analytical biochemistry.

[5]  Shi Ke,et al.  Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. , 2007, Journal of biomedical optics.

[6]  Susan S Salmond.  TAKING THE MYSTERY OUT OF RESEARCH: Box and Whisker Plots Displaying Mean, Interquartile Range, and Range , 2007, Orthopedic nursing.

[7]  M. Simpson,et al.  Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. , 2006, The American journal of pathology.

[8]  Zhen Cheng,et al.  Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. , 2006, Bioconjugate chemistry.

[9]  Nizar Mullani,et al.  Uptake of a Fluorescent Deoxyglucose Analog (2-NBDG) in Tumor Cells , 2005, Molecular Imaging and Biology.

[10]  H. Nabi,et al.  18F-FDG imaging: pitfalls and artifacts. , 2005, Journal of nuclear medicine technology.

[11]  J. Best,et al.  Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer , 2005, Journal of cellular physiology.

[12]  J. Vera,et al.  Predicting the three-dimensional structure of the human facilitative glucose transporter glut1 by a novel evolutionary homology strategy: insights on the molecular mechanism of substrate migration, and binding sites for glucose and inhibitory molecules. , 2004, Biophysical journal.

[13]  Britton Chance,et al.  NIR optical probes targeting glucose transporters , 2004, SPIE BiOS.

[14]  E. Sevick-Muraca,et al.  Near-Infrared Fluorescence Optical Imaging and Tomography , 2004, Disease markers.

[15]  F. O’Sullivan,et al.  Hypoxia and Glucose Metabolism in Malignant Tumors , 2004, Clinical Cancer Research.

[16]  J. Frangioni.  In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[17]  C. Sweep,et al.  Inhibition of protein kinase CbetaII increases glucose uptake in 3T3-L1 adipocytes through elevated expression of glucose transporter 1 at the plasma membrane. , 2003, Molecular endocrinology.

[18]  Britton Chance,et al.  Pyropheophorbide 2-deoxyglucosamide: a new photosensitizer targeting glucose transporters. , 2003, Bioconjugate chemistry.

[19]  M. Spieth,et al.  A tabulated summary of the FDG PET literature. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  Kai Licha,et al.  Cyanine dyes as contrast agents in biomedical optical imaging. , 2002, Academic radiology.

[21]  Daniel J. Hawrysz,et al.  Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents. , 2000, Neoplasia.

[22]  W C Eckelman,et al.  Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture. , 1999, Cancer research.

[23]  C. Kahn,et al.  Overexpression of Rad Inhibits Glucose Uptake in Cultured Muscle and Fat Cells* , 1996, The Journal of Biological Chemistry.

[24]  K. Siddle,et al.  Phorbol esters stimulate phosphatidylinositol 3,4,5-trisphosphate production in 3T3-L1 adipocytes: implications for stimulation of glucose transport. , 1996, The Biochemical journal.

[25]  R L Wahl,et al.  Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  G Lucignani,et al.  Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  R L Wahl,et al.  Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  G. van Kaick,et al.  Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  S. Cushman,et al.  Development of an intracellular pool of glucose transporters in 3T3-L1 cells. , 1992, The Journal of biological chemistry.

[30]  G. Holman,et al.  Trafficking of glucose transporters in 3T3-L1 cells. Inhibition of trafficking by phenylarsine oxide implicates a slow dissociation of transporters from trafficking proteins. , 1992, The Biochemical journal.

[31]  G. Gould,et al.  Phorbol ester only partially mimics the effects of insulin on glucose transport and glucose-transporter distribution in 3T3-L1 adipocytes. , 1991, The Biochemical journal.

[32]  I. Simpson,et al.  Cell surface labeling of glucose transporter isoform GLUT4 by bis-mannose photolabel. Correlation with stimulation of glucose transport in rat adipose cells by insulin and phorbol ester. , 1990, The Journal of biological chemistry.

[33]  A. Carruthers,et al.  Facilitated diffusion of glucose. , 1990, Physiological reviews.

[34]  J. Tukey,et al.  Variations of Box Plots , 1978 .

[35]  F. Jöbsis.  Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. , 1977, Science.

[36]  M. Reivich,et al.  THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.

[37]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[38]  D. Mankoff,et al.  Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by ( 18 F)Fluoromisonidazole and ( 18 F)Fluorodeoxyglucose Positron , 2004 .

[39]  L. O. Svaasand,et al.  Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. , 2000, Neoplasia.

[40]  M. Sturek,et al.  Examining glucose transport in single vascular smooth muscle cells with a fluorescent glucose analog. , 1999, Physiological research.

[41]  B. Chance,et al.  Optical method. , 1991, Annual review of biophysics and biophysical chemistry.